Keenan v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJune 7, 2018
Docket17-189
StatusUnpublished

This text of Keenan v. Secretary of Health and Human Services (Keenan v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Keenan v. Secretary of Health and Human Services, (uscfc 2018).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-189V (Not to be Published)

************************* Special Master Corcoran JOYCE KEENAN, * * Filed: May 2, 2018 Petitioner, * * Decision; Attorney’s Fees and Costs. v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * *************************

Randy M. Hitchcock, Whitfield Sharp & Hitchcock, Marblehead, MA, for Petitioner.

Jay Mason All, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION GRANTING ATTORNEY’S FEES AND COSTS1

On February 8, 2017, Joyce Keenan filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”).2 The Petition alleged that the influenza vaccine that she received on February 14, 2014, caused her to develop dermatitis on both her hands and feet. Following the filing of medical records and Respondent’s Rule 4(c) Report, Petitioner filed a motion to dismiss on February 23, 2018, expressing in her view she

1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’s website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended, 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act. would be unable to prove entitlement in this case. Thereafter, I issued a decision dismissing the case on February 28, 2018 (ECF No. 23).

Petitioner has now filed a motion requesting final attorney’s fees and costs, dated April 24, 2018. See Motion for Attorney’s Fees and Costs, dated Apr. 24, 2018 (ECF No. 25) (“Fees App.”). Petitioner requests reimbursement of attorney’s fees and costs in the combined amount of $14,063.00 ($12,463.00 in attorney’s fees, plus $1,600.00 in costs), as well as $400.00 for costs personally incurred by Petitioner. Id. at 2; Ex. 9 to Fees App. at 1 (ECF No. 25-9) (General Order No. 9 Statement). Respondent filed a document reacting to the fees application on April 25, 2018, stating that he is satisfied that the statutory requirements for an award of attorney’s fees and costs are met in this case, but deferring to my discretion the determination of the amount to be awarded. ECF No. 27 at 2-3.

Unsuccessful petitioners may be awarded reasonable fees and costs if, in the special master’s exercise of discretion, such an award is appropriate (and, as in the case of successful claims, the requested fees and costs are reasonable). I have in other decisions addressed at length the legal standard applicable to evaluating the propriety of a fees request in an unsuccessful case See, e.g, R.V. v. Sec’y of Health & Human Servs., No. 08-504V, 2016 WL 7575568 (Fed. Cl. Spec. Mstr. Nov. 28, 2016). The primary factors to be considered under such circumstances are whether (a) the petition was brought in good faith; and (b) there was reasonable basis for which the petition was brought. Section 15(e)(1); Silva v. Sec’y of Health & Human Servs., 108 Fed. Cl. 401, 405 (2012). Determining whether a petition was filed in good faith is a subjective inquiry, and can be established as long as the petitioner demonstrates an honest belief that he has suffered a compensable injury. See Lemaire v. Sec’y of Health & Human Servs., No. 13-681V, 2016 WL 5224400, at *3 (Fed. Cl. Spec. Mstr. Aug. 12, 2016). A claim’s reasonable basis involves application of objective criteria which looks to the feasibility of the claim, and not to the claim’s likelihood of success. Id. at 4.

Determining the appropriate amount of an award of reasonable attorney’s fees is a two-part process. The first part involves application of the lodestar method – “multiplying the number of hours reasonably expended3 on the litigation times a reasonable hourly rate.” Avera v. Sec’y of

3 An attorney’s reasonable hourly rate is more precisely understood to be the “prevailing market rate” in the relevant forum. Avera, 515 F.3d at 1349; Rodriguez v. Sec’y of Health & Human Servs., No. 06-559V, 2009 WL 2568468, at *2 (Fed. Cl. Spec. Mstr. July 27, 2009), mot. for rev. denied, 91 Fed. Cl. 453 (2010), aff’d, 632 F.3d 1381 (Fed. Cir. 2011). That rate is in turn determined by the “forum rule,” which bases the award rate on rates paid to similarly qualified attorneys in the forum where the relevant court sits (Washington, D.C., for Vaccine Program cases). Avera, 515 F.3d at 1348. After the hourly rate is determined, the reasonableness of the total hours expended must be considered. Sabella, 86 Fed. Cl. at 205-06. This reasonableness inquiry involves consideration of the work performed on the matter, the skill and experience of the attorneys involved, and whether any waste or duplication of effort is evident. Hensley, 461 U.S. at 434, 437.

In some cases, determining the proper hourly rate for a particular attorney requires consideration of whether there is a significant disparity between the forum rate applicable to the Vaccine Program generally and the geographic forum

2 Health & Human Servs., 515 F.3d 1343, 1347-48 (Fed. Cir. 2008) (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). The second part involves adjusting the lodestar calculation up or down to take relevant factors into consideration. Avera, 515 F.3d at 1348. This standard for calculating a fee award is considered applicable in most cases where a fee award is authorized by federal statute. Hensley v. Eckerhart, 461 U.S. 424, 429-37 (1983).

Although Petitioner was not successful in pursuing her claim, I find that the matter had sufficient reasonable basis to justify a final award of fees. Here, Respondent does not assert that the matter lacked reasonable basis prior to Petitioner’s decision to seek dismissal, nor does Respondent question Petitioner’s good faith in filing the claim. I do not find otherwise, based on my overall review of the record. Claims alleging a vaccine-induced dermatitis injury are frequently litigated in the Program, both successfully and unsuccessfully. The allegations and medical records also generally provided an evidentiary basis for the claim, despite the overall outcome. Furthermore, Petitioner acted reasonably by voluntarily dismissing this matter following an unsuccessful attempt to retain an expert who could opine as to vaccine causation, and thus did not unnecessarily run up fees.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Keenan v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/keenan-v-secretary-of-health-and-human-services-uscfc-2018.